A fluorimetric assay for metolazone in urine.
作者信息
Vose C W, Stevens P M, Muirhead D C, Palmer R F, McInnes G T
出版信息
Br J Clin Pharmacol. 1980 Feb;9(2):213-5. doi: 10.1111/j.1365-2125.1980.tb05836.x.
Abstract
摘要
相似文献
1
A fluorimetric assay for metolazone in urine.尿液中美托拉宗的荧光测定法。
Br J Clin Pharmacol. 1980 Feb;9(2):213-5. doi: 10.1111/j.1365-2125.1980.tb05836.x.
2
Determination of a Metolazone metabolite in human urine by high-performance liquid chromatography/diode-array detection, high-performance liquid chromatography/electrospray ionization mass spectrometry and gas chromatography/mass spectrometry.
Rapid Commun Mass Spectrom. 2004;18(8):917-22. doi: 10.1002/rcm.1398.
3
Dose-response relationships for spironolactone in combination with a potassium-wasting diuretic.螺内酯与排钾利尿剂联合使用时的剂量-反应关系。
Clin Pharmacol Ther. 1983 Jan;33(1):35-43. doi: 10.1038/clpt.1983.5.
4
Use of a bioassay in healthy men to evaluate diuretic-spironolactone combinations.在健康男性中使用生物测定法评估利尿剂与螺内酯的组合。
Br J Clin Pharmacol. 1983 May;15(5):564-6. doi: 10.1111/j.1365-2125.1983.tb02092.x.
5
Metolazone and spironolactone in cirrhosis and the nephrotic syndrome.美托拉宗与螺内酯用于肝硬化及肾病综合征的治疗
Clin Pharmacol Ther. 1977 Feb;21(2):234-43. doi: 10.1002/cpt1977212234.
6
Quantitation of metolazone in urine by high-performance liquid chromatography with fluorescence detection.
J Chromatogr. 1990 Dec 14;534:228-32. doi: 10.1016/s0378-4347(00)82167-2.
7
Quantitation of metolazone in plasma and urine by high-performance liquid chromatography with fluorescence detection.采用高效液相色谱-荧光检测法对血浆和尿液中的美托拉宗进行定量分析。
J Chromatogr. 1981 Feb 13;222(2):311-5. doi: 10.1016/s0378-4347(00)81067-1.
8
Relative potency of prorenoate potassium and spironolactone in attenuating diuretic induced hypokalaemia.去氧皮质酮酸钾与螺内酯在减轻利尿剂诱发的低钾血症方面的相对效价。
Br J Clin Pharmacol. 1984 Aug;18(2):169-74. doi: 10.1111/j.1365-2125.1984.tb02449.x.
9
Enhancement of diuresis with metolazone in infant paediatric cardiac intensive care patients.
Cardiol Young. 2018 Jan;28(1):27-31. doi: 10.1017/S1047951117001330. Epub 2017 Sep 11.
10
The effect of nonsteroidal agents (NSAIDs) on the pharmacokinetics and pharmacodynamics of metolazone.
Int J Clin Pharmacol Ther. 1994 Jan;32(1):12-8.
引用本文的文献
1
Stability-Indicating Spectrofluorimetric Methods for the Determination of Metolazone and Xipamide in Their Tablets. Application to Content Uniformity Testing.用于测定噻嗪类利尿剂片剂中美托拉宗和希帕胺的稳定性指示荧光分光光度法。在含量均匀度检测中的应用。
J Fluoresc. 2014 Mar;24(2):363-76. doi: 10.1007/s10895-013-1301-z. Epub 2013 Oct 4.
2
Diuretics. Clinical pharmacology and therapeutic use (Part I).利尿剂。临床药理学与治疗应用（第一部分）
Drugs. 1985 Jan;29(1):57-87. doi: 10.2165/00003495-198529010-00003.
本文引用的文献
1
Liquid chromatography: its use in the biological characterization and study of metolazone--a new diuretic.液相色谱法：其在美托拉宗生物特性鉴定及研究中的应用——一种新型利尿剂
J Chromatogr Sci. 1972 Jun 10;10(6):379-83. doi: 10.1093/chromsci/10.6.379.
2
Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure.
Clin Pharmacol Ther. 1974 Aug;16(2):322-9. doi: 10.1002/cpt1974162322.
3
Fluorometric determination of hydroflumethiazide in human plasma and urine after its oral administration.口服氢氟噻嗪后人体血浆和尿液中氢氟噻嗪的荧光测定法。
Eur J Clin Pharmacol. 1977 Jan 3;11(2):149-54. doi: 10.1007/BF00562907.
Zotero 插件